FDA OKs Packaging for OTC Loperamide to Help Stem Misuse, Abuse FDA OKs Packaging for OTC Loperamide to Help Stem Misuse, Abuse

The changes to Imodium A-D, Imodium Multi-Symptom Relief, and Be Health Loperamide HCl Capsules limit each carton to no more than 48 mg of loperamide and require unit-dose blister packaging.News Alerts
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news